Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (...
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
About this item
Full title
Author / Creator
Winer, Eric P, Prof , Lipatov, Oleg, MD , Im, Seock-Ah, MD , Goncalves, Anthony, Prof , Muñoz-Couselo, Eva, MD , Lee, Keun Seok, MD , Schmid, Peter, Prof , Tamura, Kenji, MD , Testa, Laura, MD , Witzel, Isabell, Prof , Ohtani, Shoichiro, MD , Turner, Nicholas, MD , Zambelli, Stefania, MD , Harbeck, Nadia, MD , Andre, Fabrice, MD , Dent, Rebecca, MD , Zhou, Xuan, PhD , Karantza, Vassiliki, MD , Mejia, Jaime, MD , Cortes, Javier, MD , KEYNOTE-119 investigators and KEYNOTE-119 investigators
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
SummaryBackgroundPembrolizumab showed durable antitumour activity and manageable safety in metastatic triple-negative breast cancer in the single-arm KEYNOTE-012 and KEYNOTE-086 trials. In this study, we compared pembrolizumab with chemotherapy for second-line or third-line treatment of patients with metastatic triple-negative breast cancer. Method...
Alternative Titles
Full title
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Lipatov, Oleg, MD
Im, Seock-Ah, MD
Goncalves, Anthony, Prof
Muñoz-Couselo, Eva, MD
Lee, Keun Seok, MD
Schmid, Peter, Prof
Tamura, Kenji, MD
Testa, Laura, MD
Witzel, Isabell, Prof
Ohtani, Shoichiro, MD
Turner, Nicholas, MD
Zambelli, Stefania, MD
Harbeck, Nadia, MD
Andre, Fabrice, MD
Dent, Rebecca, MD
Zhou, Xuan, PhD
Karantza, Vassiliki, MD
Mejia, Jaime, MD
Cortes, Javier, MD
KEYNOTE-119 investigators
KEYNOTE-119 investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03629997v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03629997v1
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(20)30754-3
